A new xanthine oxidase inhibitor named hydroxyakalone was isolated from the culture broth of a marine bacterium Agrobacterium aurantiacum N-81 106. Structure of hydroxyakalone was determined to be 4-amino-l//-pyrazolo[3,4-d]pyrimidine-3-one-6-ol by the spectral studies of hydroxyakalone and its permethyl derivative. The concentration to induce 50% inhibition (IC50) was 4.6^m against xanthine oxidase. found from plant sources. In a previous paper5\ we reported a new XODinhibitor, akalone from a marine bacteria, Agrobacterium aurantiacum N-81 106. Whencultivation conditions of A. aurantiacum N-81 106 were changed using a 1000 liters fermenter, akalone was not produced, and another strong XOD inhibitor was found to be produced instead of akalone. In the present paper, we describe the fermentation, isolation and structural determination of this XOD inhibitor named hydroxyakalone.
Materials and Methods

General
The UVabsorption spectrum was recorded on a Shimadzu UV-2100S recording spectrophotometer in distilled water, while NMRspectra were recorded with a Varian Unity 500 spectrometer using D2O and DMSOd6 solvents. The FABmass spectra (FAB-MS) were measured with a JEOLJMS-SX102mass spectrometer. 
Assay Method
Supernatant obtained from the fermentation broth by centrifuging at 18,600g for 5 minutes was provided as a test solution. The bioassay for XODinhibitory activity was performed according to a modified version ofNoro's method2), using XODfrom cow's milk that was obtained from Sigma Chemical Co. A mixture consisting of0.3 ml of test solution and 1.0ml of XODsolution, which was prepared at a concentration of 0.22 units/ml with 50 mM phosphate buffer, was pre-incubated for 15 minutes at 25°C. The enzymatic reaction was initiated by adding to the mixture 1.7ml of substrate solution containing xanthine at a concentration of 1.74/zg/ml. The optical density of the mixture was recorded at 290nmby time scanning while incubating at 25°C. A control mixture was also prepared in the samemannerwithout the test solution. One unit of XODactivity is defined as that producing 1 /miol of uric acid per min at 25°C. The XOD inhibitory activity is expressed as the percentage inhibition of the enzyme and is calculated by the expression (1-B/A)x 100, where A and B are the levels ofXOD activity without and with test solution, respectively. aqueous alkali and DMSO and insoluble in methanol, chloroform and^-hexane. Negative FAB-MSof hydroxyakalone showed a pseudo molecular ion (M -H)ã t m/z 166, and the molecular formula was determined to be C5H5N5O2on the basis ofHR negative FAB-MS. The UVabsorption spectrum showeda maximum at 298 nm, and the 13C NMRspectrum (Table 2) exhibited five sp2 carbons, implying the existence of a conjugated heterocyclic system. The *H NMRspectrum in DMSO-d6 showed five exchangeable protons, that is, there were no carbon-bonded protons. These data suggested that hydroxyakalone was an analog of akalone. However, no more information could be obtained from the spectra of the intact compound, and further investigation was carried out using the methyl derivative.
Methylation of hydroxyakalone with methyl iodide and silver oxide afforded several products. One of the products had the molecular formula C10H15N5O2which was indicated by HR FAB-MS ( Table 1) . The difference of molecular formulas between hydroxyakalone and its methylate suggested that five methyl groups were introduced into hydroxyakalone. The five methyl groups introduced were assigned to and the 7a-carbon (Fig. 1) , which confirmed the partial structure from N-5 to the 7a-carbon. A NOEwas observed between N(CH3)2, which was long range coupled with C-4, and 5-NCH3, implying the bonding between N-5 and C-4. Since the neighboring atoms of the sp2 quarternary carbon at 8C 104.35 were carbons based on its chemical shift, the neighboring atoms must be C-4, C-7a and C-3. Thus, the connectivity of C-3 to C-4 was established.
A NOE between N(CH3)2 and 3-OCH3, which was long range coupled with C-3, also assisted this connectivity.
The partial structure C-3 through C-7a contained all elements except two nitrogens. Thus the whole structure of methylated hydroxyakalone was determined to be as shownin Fig.  2 , introducing the remaining two nitrogens between the 3-and 7a-carbons. The chemical shifts of C-3, C-3a and C-7a were reasonable for this structure. In the HMBC study, 4/CH coupling was observed between 5-NCH3
protons and the 3a-carbon instead of 3/CH coupling with the 4-carbon. The total assignments of XHand 13C NMR signals of methylated hydroxyakalone are listed in Table   3 .
Owing to the establishment of the structure of methylated hydroxyakalone, the novel structure of hydroxyakalone was determined to be 4-amino-lifpyrazolo[3,4-<i]pyrimidine-3-one-6-ol as shown in Fig.   2 where the 6-position of akalone is substituted by a hydroxy group. In its structure, a contribution of 6-one and 3-ol forms was thought to exist.
XODInhibitory Activity of Hydroxyakalone
Hydroxyakalone showed XOD inhibitory activity stronger than akalone. The 50%inhibition concentration (IC50) of hydroxyakalone was 4.6/im, compared with 16.9 /im for akalone and 4.0 /im for allopurinol.
